Literature DB >> 1520787

Should all patients with candidemia be treated with antifungal agents?

J E Edwards.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1520787     DOI： 10.1093/clind/15.3.422

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  6 in total

1.  Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients. Canadian Candidemia Study Group.

Authors:  P Phillips; S Shafran; G Garber; C Rotstein; F Smaill; I Fong; I Salit; M Miller; K Williams; J M Conly; J Singer; S Ioannou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-05       Impact factor: 3.267

2.  Successful treatment of catheter-associated fungemia due to Candida krusei and Trichosporon beigelii in a leukemic patient receiving prophylactic itraconazole.

Authors:  S Spánik; T Kollár; J Gyarfás; A Kunová; V Krcméry
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-02       Impact factor: 3.267

3.  Significance of oral Candida infections in children with cancer.

Authors:  Márta Alberth; László Majoros; Gabriella Kovalecz; Emese Borbás; István Szegedi; Ildikó J Márton; Csongor Kiss
Journal:  Pathol Oncol Res       Date:  2006-12-25       Impact factor: 3.201

4.  Assessment of detection of Candida mannoproteinemia as a method to differentiate central venous catheter-related candidemia from invasive disease.

Authors:  C Girmenia; P Martino; F De Bernardis; A Cassone
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

5.  Duration of antifungal treatment and development of delayed complications in patients with candidaemia.

Authors:  A M L Oude Lashof; J P Donnelly; J F G M Meis; J W M van der Meer; B J Kullberg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-01-25       Impact factor: 3.267

6.  Hematogenous endophthalmitis in a patient with candidemia.

Authors:  S K Na; K J Park; H J Kim; S C Lee
Journal:  Korean J Intern Med       Date:  1997-06       Impact factor: 2.884
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.